CP and COVID-19: Nevertheless, the CP may play a critical role in driving the complement-related pathology in COVID-19, an inference that is supported by the documented association between early virus-specific IgM and/or IgG Ab responses and complement hyperactivation, leading to tissue injury in critically ill patients [12,43,44].